You
LB

Lexaria Bioscience Corp.

Company · Health · A1
Statements1
Sightings1
Years covered2023 – now
Primary sourceSEC Form 424B4
All statements
2023 – nowCurrentOur mission is to obtain FDA approval for a DehydraTECH – CBD drug for use on hypertension.Mission · Product offering · SEC Form 424B4, filed 2023-05-10
Organization
Type
Company
Industry
Health
Location
A1, US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗